Source: In Vitro Sciences

IVS: SVERICA CAPITAL MANAGEMENT ANNOUNCES INVESTMENT IN IN VITRO SCIENCES

Sverica Capital Management LP (“Sverica”), a private equity investment firm, today announced that on October 1 it made a strategic investment in In Vitro Sciences LLC (“IVS” or the “Company”), which operates a network of fertility clinics in the United States

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Derek M. Larkin's photo - CEO of IVS

CEO

Derek M. Larkin

CEO Approval Rating

90/100

Read more